Comparison |
| Alternate Manufacturer Number |
| | 2348563 | 2348530 | |
| Country of Origin |
Ireland | United States | Unknown | Unknown | Unknown |
| Generic Drug Code |
50034 | 43859 | 49791 | 49791 | 55887 |
| Generic Drug Name |
Pneumococcal 15-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free | Pneumococcal 23 Vaccine Polyvalent | Pneumococcal 20-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free | Pneumococcal 20-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free | Pneumococcal 21-valent Conjugate Vaccine |
| NDC Number |
00006432903 | 00006483703 | 00005200010 | 00005200002 | 00006434702 |
| Product Dating |
McKesson Acceptable Dating: we will ship >= 180 days | McKesson Acceptable Dating: we will ship >= 180 days | McKesson Acceptable Dating: we will ship >= 180 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 180 days |
| Strength |
2 mcg - 4 mcg - 30 mcg / 0.5 mL | 25 mcg / 0.5 mL | 2.2 mcg - 4.4 mcg / 0.5 mL | 2.2 mcg - 4.4 mcg / 0.5 mL | 84 mcg / 0.5 mL |
| Type |
Intramuscular | Intramuscular or Subcutaneous | Intramuscular | Intramuscular | Intramuscular |
| User |
Indicated for People 6 Weeks of Age and Older | Indicated for People 50 Years of Age and Older | Indicated for People 6 Weeks of Age and Older | Indicated for People 6 Weeks of Age and Older | |
| Application |
Pneumonia Vaccine | Pneumonia Vaccine | Pneumonia Vaccine | Pneumonia Vaccine | Pneumonia Vaccine |
| Container Type |
Prefilled Syringe | Prefilled Syringe | Prefilled Syringe | Prefilled Syringe | Prefilled Syringe |
| Dosage Form |
Injection | Injection | Injection | Injection | Injection |
| Storage Requirements |
Requires Refrigeration | Requires Refrigeration | Requires Refrigeration | Requires Refrigeration | Requires Refrigeration |
| UNSPSC Code |
51201615 | 51201615 | 51201615 | 51201615 | 51201615 |
| Volume |
0.5 mL | 0.5 mL | 0.5 mL | 0.5 mL | 0.5 mL |
| Features and Benefits |
- VAXNEUVANCE™ is a vaccine indicated for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in individuals 6 weeks of age and older
- Children: Administer VAXNEUVANCE as a 4-dose series at 2, 4, 6 and 12 through 15 months of age
- Adults: Administer VAXNEUVANCE as a single dose in adults 18 years of age and older
- 10 Per Package
|
- PNEUMOVAX 23 is a vaccine indicated for active immunization for the prevention of pneumococcal disease caused by the 23 serotypes contained in the vaccine
- PNEUMOVAX 23 is approved for use in persons 50 years of age or older and persons aged >2 years who are at increased risk for pneumococcal disease
- Box of 10 single-dose, pre-filled Luer-Lok™ syringes with tip caps, color coded with a violet plunger rod and purple stripe on the syringe labels and cartons
- Store unopened and opened vials at 2° - 8°C (36° - 46°F)
|
|
|
- Carton of ten single-dose prefilled Luer Lock syringe with tip cap, containing 1 dose of 0.5 mL
|
